Unknown

Dataset Information

0

Pre-admission NT-proBNP improves diagnostic yield and risk stratification - the NT-proBNP for EValuation of dyspnoeic patients in the Emergency Room and hospital (BNP4EVER) study.


ABSTRACT: Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) level is useful to diagnose or exclude acutely decompensated heart failure (ADHF) in dyspnoeic patients presenting to the emergency department (ED).To evaluate the impact of ED NT-proBNP testing on admission, length of stay (LOS), discharge diagnosis and long-term outcome.Dyspnoeic patients were randomized in the ED to NT-proBNP testing. Admission and discharge diagnoses, and outcomes were examined.During 17 months, 470 patients were enrolled and followed for 2.0±1.3 years. ADHF likelihood, determined at study conclusion by validated criteria, established ADHF diagnosis as unlikely in 86 (17%), possible in 120 (24%), and likely in 293 (59%) patients. The respective admission rates in these subgroups were 80, 91, and 96%, regardless of blinding, and 61.9% of blinded vs. 74.5% of unblinded ADHF-likely patients were correctly diagnosed at discharge (p=0.029), with similar LOS. 2-year mortality within subgroups was unaffected by test, but was lower in ADHF-likely patients with NT-proBNP levels below median (5000 pg/ml) compared with those above median (p=0.002). Incidence of recurrent cardiac events tracked NT-proBNP levels.ED NT-proBNP testing did not affect admission, LOS, 2-year survival, or recurrent cardiac events among study patients but improved diagnosis at discharge, and allowed risk stratification even within the ADHF-likely group. (ClinicalTrials.gov#NCT00271128).

SUBMITTER: Meisel SR 

PROVIDER: S-EPMC3760533 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pre-admission NT-proBNP improves diagnostic yield and risk stratification - the NT-proBNP for EValuation of dyspnoeic patients in the Emergency Room and hospital (BNP4EVER) study.

Meisel Simcha R SR   Januzzi James L JL   Medvedovski Margarita M   Sharist Moshe M   Shochat Michael M   Ashkar Jalal J   Peschansky Pavel P   Haim Shmuel Bar SB   Blondheim David S DS   Glikson Michael M   Shotan Avraham A  

European heart journal. Acute cardiovascular care 20120601 2


<h4>Background</h4>Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) level is useful to diagnose or exclude acutely decompensated heart failure (ADHF) in dyspnoeic patients presenting to the emergency department (ED).<h4>Aim</h4>To evaluate the impact of ED NT-proBNP testing on admission, length of stay (LOS), discharge diagnosis and long-term outcome.<h4>Methods</h4>Dyspnoeic patients were randomized in the ED to NT-proBNP testing. Admission and discharge diagnoses, and outcomes were ex  ...[more]

Similar Datasets

| S-EPMC8426942 | biostudies-literature
| S-EPMC9363055 | biostudies-literature
| S-EPMC4201035 | biostudies-literature
| S-EPMC5210241 | biostudies-literature
| S-EPMC6224094 | biostudies-literature
| S-EPMC10377000 | biostudies-literature
| S-EPMC9140882 | biostudies-literature
| S-EPMC9119890 | biostudies-literature
| S-EPMC4799784 | biostudies-literature
| S-EPMC5907582 | biostudies-literature